Company intelligence / Profile preview

Guerbet

Villepinte, Île-de-France, Franceguerbet.com ↗

Ownership: Public · GBT
Employees: ~2600
Development stage: Commercial

Overview

Guerbet is a global leader in medical imaging with a comprehensive portfolio of contrast media and related devices that are commercially available worldwide. The company has also advanced into digital health with AI-powered diagnostic tools such as DUOnco Liver, which recently received CE marking for liver lesion detection[5]. It maintains an active pipeline of new products and clinical trials focused on improving radiological diagnostics.

Therapeutic areas: OtherGastroenterology
Modalities: Contrast agents (iodinated, gadolinium-based)Medical devices for imaging deliveryDigital and AI solutions for imaging[2][5][7]
Industry: Medical Imaging

Drug pipeline

4 assets

gadoterate meglumine

Commercial

Indications: MRI contrast

3 more assets in the full pipeline.

Request access →

Partnerships

Nuclidium AG – partnership to advance copper-based radiotheranostics (2024)[5]

Financials

Market cap: $0
Total revenue: $71.6M
Enterprise value: $141.2M

Beyond the preview

Go deeper on Guerbet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guerbet.

Explore the full profile